According to GuruFocus Insider Data, these are the largest CEO buys during the past week.
Energy Transfer CEO bought shares
Energy Transfer LP (ET, Financial) CEO Kelcy L. Warren bought 1 million shares on Nov. 19 at a price of $14.93. The price of the stock has decreased by 4.69% since.
Energy Transfer is a limited partnership company. Through its subsidiaries, the company owns and operates natural gas gathering systems, natural gas intrastate pipeline systems and gas processing plants. The company has a market cap of $37.24 billion. Its shares traded at $14.23 with a price-earnings ratio of 12.84 as of Nov. 23.
Net income for the third quarter of 2018 was $371 million, an increase of $119 million compared to the three months ended Sept. 30, 2017.
Warren bought 2 million shares on Nov. 13 at a price of $15.55. The price of the stock has decreased by 8.49% since.
Director Ray C. Davis bought 316,000 shares on Nov. 12 at a price of $15.8. The price of the stock has decreased by 9.94% since.
American Assets Trust CEO bought 29,263 shares
American Assets Trust Inc. (AAT, Financial) Chairman, CEO, President and 10% Owner Ernest S. Rady bought 29,263 shares during the past week at an average price of $39.53.
American Assets Trust is a self-administered real estate investment trust based in the United States. The company mainly invests in, operates, and develops retail, office, residential and mixed-use properties in California, Oregon and Hawaii. The company has a market cap of $2.54 billion. Its shares traded at $39.42 with a price-earnings ratio of 92.10 as of Nov. 23.
Net income for the third quarter of 2018 was $10.4 million compared to net income of $9.1 million for the three months ended Sept. 30, 2017.
Rady bought 21,608 shares on Nov. 12 at a price of $39.22; 33,967 shares on Nov. 15 at a price of $38.95; 19,627 shares on Nov. 19 at a price of $39.42; and 9,636 shares on Nov. 23 at a price of $39.75. The price of the stock has decreased by 0.83% since.
Kellogg CEO bought 17,825 shares
Kellogg Co. (K, Financial) Chairman, President, CEO/Trustee and 10% Owner Steven A. Cahillane bought 17,825 shares on Nov. 19 at a price of $61.63. The price of the stock has increased by 0.18% since.
Kellogg is engaged in the manufacturing and marketing of ready-to-eat cereal and convenience foods. Its products include cereal, cookies, crackers and other packaged foods. The company has a market cap of $21.43 billion. Its shares traded at $61.74 with a price-earnings ratio of 12.21 as of Nov. 23.
Net income for the third quarter of 2018 was $380 million compared to $288 for the prior-year period.
Chief Financial Officer Fareed A. Khan bought 8,190 shares on Nov. 11 at a price of $62.14. The price of the stock has decreased by 0.64% since.
10% Owner W. K. Kellogg Foundation Trust sold 180,000 shares on Nov. 20 at a price of $62.24. The price of the stock has decreased by 0.8% since.
ASGN CEO bought 15,000 shares
ASGN Inc. (ASGN, Financial) CEO Peter T. Dameris bought 15,000 shares on Nov. 20 at a price of $65.92. The price of the stock has increased by 2.93% since.
ASGN, formerly On Assignment Inc., provides skilled and professionals in the growing life sciences, health care and technology sectors. The company's operating business segments are Apex and Oxford. The company has a market cap of $3.56 billion. Its shares traded at $67.85 with a price-earnings ratio of 20.07 as of Nov. 23.
Net income for the third quarter of 2018 was $49.2 million compared to $34.9 million for the comparable prior-year period.
President of ECS George H. Wilson bought 3,700 shares on Nov. 14 at a price of $66.76. The price of the stock has increased by 1.63% since.
Director Brian J. Callaghan bought 15,000 shares on Nov. 5 at a price of $68.03. The price of the stock has decreased by 0.26% since.
Board Adviser Joseph Wendell Dyer bought 250 shares on Oct. 29 at a price of $66.77. The price of the stock has increased by 1.62% since.
Madrigal Pharmaceuticals CEO bought 8,000 Shares
Madrigal Pharmaceuticals Inc. (MDGL, Financial) CEO Paul A. Friedman bought 8,000 shares during the past week at an average price of $120.94.
Madrigal Pharmaceuticals is a company focused on the development of novel compounds for the treatment of cardiovascular-metabolic diseases and nonalcoholic steatohepatitis (NASH). The company has a market cap of $1.75 billion. Its shares traded at $113.38 as of Nov. 23.
Net loss for the third quarter of 2018 was $8.51 million compared to $8.36 million for the prior-year period.
Friedman bought 4,000 shares on Nov. 19 at a price of $124 and 4,000 shares on Nov. 20 at a price of $117.88. The price of the stock has decreased by 3.82% since.
Director and 10% Owner Fred B. Craves bought 2,000 shares on Nov. 19 at a price of $124.69. The price of the stock has decreased by 9.07% since.
For the complete list of stocks that were bought by their company CEOs, go to: CEO Buys.
Disclosure: I do not own stock in any of the companies mentioned.